Ocugen (OCGN) Net Equity Issued and Repurchased (2015 - 2026)

Ocugen (OCGN) posted Net Equity Issued and Repurchased of $22.5 million for Q1 2026, up 1372.51% on a QoQ basis from $1.5 million in Q4 2025.

Ocugen (OCGN) Net Equity Issued and Repurchased (2015 - 2026) Analysis & Trends

Ocugen's Net Equity Issued and Repurchased history runs 10 years deep, the most recent figure standing at $22.5 million for Q1 2026.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $22.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.0 million (up 2835.33% YoY) and the FY2025 annual result came in at $19.9 million, down 48.51% from the prior year.
  • Net Equity Issued and Repurchased was $22.5 million for Q1 2026 at Ocugen, up from $1.5 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $50.2 million in Q1 2022 and bottomed at -$145000.0 in Q1 2024.
  • A 5-year average of $8.8 million and a median of $1.3 million in 2024 frame the typical range for Net Equity Issued and Repurchased.
  • Peak annual rise in Net Equity Issued and Repurchased reached 6031.25% in 2024, while the deepest fall reached 102.53% in 2024.
  • Ocugen's Net Equity Issued and Repurchased stood at $8.4 million in 2022, then plunged by 99.81% to $16000.0 in 2023, then surged by 6031.25% to $981000.0 in 2024, then surged by 55.76% to $1.5 million in 2025, then jumped by 1372.51% to $22.5 million in 2026.
  • Business Quant data shows OCGN's Net Equity Issued and Repurchased at $22.5 million in Q1 2026, $1.5 million in Q4 2025, and $981000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Ocugen 63.79 Mn 63.79 Mn - 22.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 22.50 Mn
Mar 31, 2026 22.50 Mn
Dec 31, 2025 1.53 Mn
Dec 31, 2025 1.53 Mn
Dec 31, 2024 981,000.00
Dec 31, 2024 981,000.00
Mar 31, 2024 -145,000.00
Mar 31, 2024 -145,000.00
Dec 31, 2023 16,000.00
Dec 31, 2023 16,000.00
Sep 30, 2023 98,000.00
Sep 30, 2023 98,000.00
Jun 30, 2023 14.96 Mn
Jun 30, 2023 14.96 Mn
Mar 31, 2023 5.73 Mn
Mar 31, 2023 5.73 Mn
Dec 31, 2022 8.43 Mn
Dec 31, 2022 8.43 Mn
Sep 30, 2022 603,000.00
Sep 30, 2022 603,000.00